DOI: 10.1055/s-00035331

Revista Urología Colombiana / Colombian Urology Journal

References

U.S. Food and Drug Administration (FDA).
Summary products characteristicas: Mirabegron (Myrbetriq).

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf Published 2012. Accessed June 1, 2020.

Download Bibliographical Data

Search in: